Publication | Open Access
Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study)
114
Citations
79
References
2018
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1